Results 41 to 50 of about 1,305 (155)

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Responsive neurostimulation for focal motor status epilepticus

Annals of Clinical and Translational Neurology, 2021
No clear evidence‐based treatment paradigm currently exists for refractory and super‐refractory status epilepticus, which can result in significant mortality and morbidity.
Jimmy C. Yang, Nitish M. Harid, Fábio A. Nascimento, Vasileios Kokkinos, Abigail Shaughnessy, Alice D. Lam, M. Brandon Westover, Thabele M. Leslie‐Mazwi, Leigh R. Hochberg, Eric S. Rosenthal, Andrew J. Cole, Robert M. Richardson, Sydney S. Cash   +12 more
doaj   +1 more source

Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes

Epilepsia Open, EarlyView.
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola, Marica Rubino, Antonella Riva, Pasquale Striano   +3 more
wiley   +1 more source

Non Ketotic Hyperosmolar Hyperglycemia presenting as Epilepsia Partialis Continua.(An unusual presentation of a common disorder) [PDF]

Libyan Journal of Medicine, 2008
We report a patient with epilepsia partialis continua (EPC) associated with non ketotic hyperosmolar hyperglycemia. EPC is an uncommon presentation of nonketotic hyperglycemia.
Kamha A
doaj  

STATUS EPILEPTICUS IN A PATIENT WITH RASMUSSEN’S ENCEPHALITIS

Alʹmanah Kliničeskoj Mediciny, 2016
We describe clinical case of Rasmussen's encephalitis in a 24-year-old woman that occurred during her hospital stay. Its clinical manifestations included a  clonic movement disorder and partial epilepsy.
A. S. Kotov A.S., Yu. V. Eliseev, E. I. Semenova, Yu. V. Tokareva, M. V. Romanova, M. S. Bunak, I. G. Rudakova   +6 more
doaj   +1 more source

Rituximab in Rasmussen’s encephalitis: A single center experience and review of the literature

Epilepsy & Behavior Reports, 2022
Rasmussen's encephalitis (RE) is a rare chronic inflammatory disease of the brain resulting in unilateral hemispheric atrophy with drug-resistant focal epilepsy associated with a variable degree of progressive hemiparesis and cognitive decline.
Sujit A. Jagtap, Sandeep Patil, Aniruddha Joshi, Nilesh Kurwale, Vivek Jain, Yogeshwari Deshmukh   +5 more
doaj   +1 more source

Defining the end point of status epilepticus: A scoping review and framework for standardization

Epilepsia, Volume 67, Issue 6, Page 2673-2688, June 2026.
Abstract Status epilepticus (SE) is a life‐threatening neurological emergency with consensus‐driven definitions for onset but no standardized criteria for its end point. This gap creates uncertainty in research and clinical practice. We conducted a scoping review to evaluate how end points have been defined in SE research and to identify key areas of ...
Fawad A. Khan, Margaret T. Gopaul, Samuel L. Carter, Anil Chimakurthy, Summer Skelton, Lawrence J. Hirsch, Eugen Trinka   +6 more
wiley   +1 more source

Neuroinflammation in GAD65 Antibody‐Associated Epilepsy Measured Using [18F]DPA‐714 PET/MRI

Annals of Clinical and Translational Neurology, Volume 13, Issue 5, Page 1066-1072, May 2026.
ABSTRACT The timing for initiating immunotherapy in patients with glutamic acid decarboxylase 65 (GAD65) antibody‐associated epilepsy is a challenge. We used the translocator protein radioligand [18F]DPA‐714 and PET to evaluate brain microglial activation.
Jingjing Chen, Yuying Zhang, Heyu Zhang, Jinming Zhang, Ningning Wang, Xintong Guo, Yicong Liu, Yue Liu, Xiangsong Zhang, Ziyi Chen, Guanzhong Ni   +10 more
wiley   +1 more source

The epileptologist's perspective of focal cortical dysplasia type 3: From concept to management

Epilepsia, Volume 67, Issue 3, Page 1017-1031, March 2026.
Abstract The recent International League Against Epilepsy (ILAE) official and updated classification of focal cortical dysplasia (FCD) includes a third type—FCD type 3—characterized by architectural abnormalities (cortical dyslamination) associated with another “principal” lesion: hippocampal sclerosis (HS), developmental tumors, vascular malformations,
André Palmini, Francine Oliveira, Eliseu Paglioli, Harvey Sarnat, Ricardo Paganin, Ricardo Soder, William Martins, Rafael Paglioli, Thomas Frigeri, Fernanda Schuh, Vicenzo Zarpellon   +10 more
wiley   +1 more source

Electroclinical Dissociation in Generalized Epilepsy: A Video‐EEG Case From Sub‐Saharan Africa

Case Reports in Medicine, Volume 2026, Issue 1, 2026.
Introduction Functional neurological symptoms, specifically functional dissociative seizures (FDS), frequently coexist with epilepsy and pose severe diagnostic challenges, particularly in resource‐limited settings where video‐electroencephalography (video‐EEG) access is scarce.
Yihealem Yabebal Ayele, Wang Chun Kwok
wiley   +1 more source